Article
An assessment of prognostic immunity markers in breast cancer
25 Oct 2018
Abstract excerpt
Abstract Tumor-infiltrating lymphocytes (TIL) and immunity gene signatures have been reported to be significantly prognostic in breast cancer but have not yet been applied for calculation of risk of recurrence in clinical assays. A compact set of 17 immunity genes was derived herein from an Affymetrix-derived gene expression dataset including 1951 patients (AFFY1951). The 17 immunity genes demonstrated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
